On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

But now, Abbott’s FreeStyle Libre 2 and 3 have received the first and only FDA clearance that allows patients to keep their ...

A major development towards the goal of patient and provider choice, the cloud-to-cloud integration will provide an automatic ...

Abbott today announced that its FreeStyle Libre 2 and 3 systems can now be worn during common imaging procedures, such as X-rays, CT scans and MRIs*. The U.S. Food and Drug Administration (FDA) ...

The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...

Abbott announced today that the FDA said users can wear the FreeStyle Libre 2 and 3 CGMs during common imaging procedures.

Now iLet Users Have a Choice of iCGMs to Customize Their Diabetes ManagementIRVINE, CA / ACCESSWIRE / October 30, 2024 / Beta ...

The research was conducted by Abbott's FreeStyle Libre, creators of continuous glucose sensing technology, in anticipation of ...

FreeStyle Libre continues to gain market share and driving the diabetes sales growth for Abbott. Abbott maintains its total 2024 revenue guidance of 9.5% to 10% growth on an organic basis.